Generic Rosiglitazone and Glimepiride

At this time, there is no generic version of rosiglitazone and glimepiride because it is protected by a patent. The patent expires in 2012, at which time a generic rosiglitazone and glimepiride could be manufactured and sold. However, there are other circumstances that could come up to extend that date past 2012, including other patents for specific uses of the medication or lawsuits.

 

Generic Rosiglitazone and Glimepiride: An Overview

Rosiglitazone and glimepiride (Avandaryl®) is a prescription medication that has been licensed to treat type 2 diabetes. The medication is a combination of two different diabetes drugs: rosiglitazone maleate (Avandia®) and glimepiride (Amaryl®).
 
Rosiglitazone and glimepiride is manufactured by GlaxoSmithKline. It is currently under the protection of a patent that prevents any generic versions from being manufactured in the United States. Yet, if you search the Internet for "generic rosiglitazone and glimepiride," you may find a number of companies selling it. The fact is that these medicines are fake, substandard, and potentially dangerous. There may be generic rosiglitazone and glimepiride available from another country, but there is really no way of knowing if you are getting the genuine drug or not. You should not buy any generic rosiglitazone and glimepiride until there is an approved generic available.
 

When Will Generic Rosiglitazone and Glimepiride Be Available?

The first patent for rosiglitazone and glimepiride currently expires in 2012. This is the earliest possible date that a generic version could become available. However, there are other circumstances that could come up to extend the exclusivity period of rosiglitazone and glimepiride beyond 2012. This could include such things as other patents for specific uses of the drug or lawsuits. Once rosiglitazone and glimepiride goes off patent, there may be several companies that manufacture a generic version of the drug.
 
(Generic Rosiglitazone and Glimepiride Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;